|
Title
|
|
|
|
Use of nonspecific protease inhibitors in research : an underestimated problem
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| For many proteases, highly potent and selective inhibitors are commercially available now, but researchers often keep using older aspecific compounds: an underestimated problem. Here, we refer to such a case and advocate using specific protease inhibitors at appropriate concentrations to make correct conclusions on cardiac Angiotensin metabolism and more on peptide metabolism in general. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Journal of the American College of Cardiology. - New York, N.Y.
|
|
|
Publication
|
|
|
|
New York, N.Y.
:
2021
|
|
|
ISSN
|
|
|
|
0735-1097
|
|
|
DOI
|
|
|
|
10.1016/J.JACC.2021.05.034
|
|
|
Volume/pages
|
|
|
|
78
:5
(2021)
, p. 542-543
|
|
|
ISI
|
|
|
|
000679372200016
|
|
|
Pubmed ID
|
|
|
|
34325847
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|